Search This Blog

Thursday, July 29, 2021

Cassava Sciences Announces Positive Cognition Data With Simufilam in Alzheimer’s

 

  • Simufilam Significantly Improves Cognition in Patients with Alzheimer’s in Interim Analysis of Open-label Study at 9 Months

  • Cognition Improved 3.0 Points on ADAS-Cog at 9 Months (p<0.001)

  • Cognitive Improvements Track with Biomarker Improvements

  • No Behavior Disorders in Over 50% of Patients

  • No Safety Issues

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.